tiprankstipranks
Advanced Proteome Therapeutics Corporation (TSE:APC)
TSXV:APC

Advanced Proteome Therapeutics (APC) Financial Statements

0 Followers

Advanced Proteome Therapeutics Financial Overview

Advanced Proteome Therapeutics's market cap is currently ―. The company's EPS TTM is C$; its P/E ratio is ―; Advanced Proteome Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Jan 23Oct 22Jul 22Apr 22Jan 22
Income Statement-
Total Revenue-$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT$ -320.80K$ -245.62K$ -109.95K$ -502.23K$ 591.42K
EBITDA-$ -244.45K$ -108.79K$ -501.07K$ 592.58K
Net Income Common Stockholders$ -277.99K$ -209.71K$ -76.16K$ -467.85K$ 627.77K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 292.46K$ 312.16K$ 544.43K$ 761.60K$ 772.94K
Total Assets$ 326.09K$ 399.05K$ 636.41K$ 855.08K$ 853.88K
Total Debt$ 388.55K$ 320.39K$ 331.77K$ 612.90K$ 406.01K
Net Debt$ 96.09K$ 8.22K$ -212.66K$ -148.70K$ -366.93K
Total Liabilities$ 1.46M$ 1.25M$ 1.49M$ 2.01M$ 1.50M
Stockholders Equity$ 357.59K$ 579.77K$ 1.07M$ 719.86K$ 1.19M
Cash Flow-
Free Cash Flow-$ -252.26K$ -223.08K$ -215.35K$ -125.12K
Operating Cash Flow$ -372.80K$ -252.26K$ -223.08K$ -215.35K$ -126.86K
Investing Cash Flow$ -35.80K$ 0.00$ -1.00$ 0.00$ 1.74K
Financing Cash Flow$ 100.79K-$ 5.91K$ 204.01K$ 219.51K
Currency in USD

Advanced Proteome Therapeutics Earnings and Revenue History

Advanced Proteome Therapeutics Debt to Assets

Advanced Proteome Therapeutics Cash Flow

Advanced Proteome Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis